ITCI
ClearBridge Investments’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-1,686,384
| Closed | -$141M | – | 753 |
|
2024
Q4 | $141M | Sell |
1,686,384
-43,345
| -3% | -$3.62M | 0.11% | 181 |
|
2024
Q3 | $127M | Buy |
1,729,729
+8,119
| +0.5% | +$594K | 0.1% | 200 |
|
2024
Q2 | $118M | Sell |
1,721,610
-22,941
| -1% | -$1.57M | 0.1% | 201 |
|
2024
Q1 | $121M | Buy |
1,744,551
+191,416
| +12% | +$13.2M | 0.1% | 225 |
|
2023
Q4 | $111M | Buy |
1,553,135
+149,534
| +11% | +$10.7M | 0.1% | 223 |
|
2023
Q3 | $73.1M | Sell |
1,403,601
-10,144
| -0.7% | -$528K | 0.07% | 254 |
|
2023
Q2 | $89.5M | Buy |
1,413,745
+363,870
| +35% | +$23M | 0.08% | 241 |
|
2023
Q1 | $56.9M | Buy |
1,049,875
+390,493
| +59% | +$21.1M | 0.05% | 295 |
|
2022
Q4 | $34.9M | Buy |
659,382
+8,099
| +1% | +$429K | 0.03% | 375 |
|
2022
Q3 | $30.3M | Buy |
651,283
+446,112
| +217% | +$20.8M | 0.03% | 379 |
|
2022
Q2 | $11.7M | Sell |
205,171
-35,257
| -15% | -$2.01M | 0.01% | 518 |
|
2022
Q1 | $14.7M | Sell |
240,428
-90,742
| -27% | -$5.55M | 0.01% | 522 |
|
2021
Q4 | $17.3M | Sell |
331,170
-102,148
| -24% | -$5.35M | 0.01% | 502 |
|
2021
Q3 | $16.2M | Sell |
433,318
-40,075
| -8% | -$1.49M | 0.01% | 526 |
|
2021
Q2 | $19.3M | Sell |
473,393
-2,119
| -0.4% | -$86.5K | 0.01% | 519 |
|
2021
Q1 | $16.1M | Sell |
475,512
-146,233
| -24% | -$4.96M | 0.01% | 521 |
|
2020
Q4 | $19.8M | Sell |
621,745
-24,776
| -4% | -$788K | 0.02% | 470 |
|
2020
Q3 | $16.6M | Buy |
646,521
+20,379
| +3% | +$523K | 0.01% | 457 |
|
2020
Q2 | $16.1M | Buy |
626,142
+114,764
| +22% | +$2.95M | 0.01% | 443 |
|
2020
Q1 | $7.86M | Buy |
511,378
+193,769
| +61% | +$2.98M | 0.01% | 508 |
|
2019
Q4 | $10.5M | Sell |
317,609
-467,529
| -60% | -$15.5M | 0.01% | 542 |
|
2019
Q3 | $5.87M | Buy |
+785,138
| New | +$5.87M | 0.01% | 577 |
|